Dr. Jeraldine S Keane-dreyer, PH.D. Psychologist - Counseling Medicare: Medicare Enrolled Practice Location: 32 Tandberg Trl, Suite 4, Windham, ME 04062 Phone: 207-655-9008 Fax: 207-655-9005 |
Mrs. Reine E. Tracy Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 408 Gray Rd, Windham, ME 04062 Phone: 207-892-1820 Fax: 207-892-1826 |
Dr. Kathleen Long, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 508 Gray Rd, Windham, ME 04062 Phone: 252-349-0219 |
Cathy Kelso Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 627 River Rd, Windham, ME 04062 Phone: 207-615-4823 |
Dr. Robert Williams, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 24 Neal Rd, Windham, ME 04062 Phone: 207-892-1205 |
James M Moran, EDD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 110 Tandberg Trl, Windham, ME 04062 Phone: 207-892-7999 |
Mr. James Babcock Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 228 Windham Center Rd, Windham, ME 04062 Phone: 207-892-1810 Fax: 207-892-1813 |
News Archive
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
St. Louis College of Pharmacy and Washington University School of Medicine in St. Louis are joining forces to find better, safer and more effective ways to use prescription medications to improve health. Researchers from the two institutions are collaborating to create the Center for Clinical Pharmacology.
Increased production of the amyloid-beta (Abeta) peptide can lead to Abeta aggregation and buildup in the brain and rare familial forms of early onset Alzheimer disease (AD).
May is Healthy Vision Month when the National Eye Institute encourages everyone to make eye health a priority. This message is especially important for women, who make up two-thirds of all people living with blindness or visual impairment from diseases such as age-related macular degeneration, glaucoma, and cataract.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
› Verified 5 days ago